Subscribe

China Resources Medical Holdings Company Limited (1515.HK)

HKD2.46 +0.04 (+1.65%)
CN HKSE Healthcare Medical - Care Facilities
Address Kunlun Center Office Building 100069
Beijing, CN
CEO Chuang Zhang
IPO 2013-11-29
ISIN KYG2133W1087

Explore sections of this company profile

Description

Operating as an investment holding firm, China Resources Medical Holdings Company Limited delivers a spectrum of healthcare services, encompassing general medical care, hospital administration, and advisory functions within the People's Republic of China. Its business activities are structured into three main divisions: hospitals it directly owns, facilities managed under Invest-Operate-Transfer (IOT) or Operate-Transfer (OT) agreements, and other ancillary operations. The company further provides group purchasing solutions and various services derived from its hospital network. A key component of its strategy involves managing and operating external hospitals and clinics through its IOT model. Additionally, the enterprise is active in the sale of pharmaceuticals, medical apparatus, medical consumables, and specialized equipment. Established in 2007, the company adopted its current name, China Resources Medical Holdings Company Limited, in October 2018, having previously been known as China Resources Phoenix Healthcare Holdings Company Limited. Its corporate headquarters are located in Beijing, People's Republic of China.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
HKD2.46 +0.04 (+1.65%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
3M
Beta
0.53
Float Shares
816.44M
Free Float %
64.6%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
+0.39% +1.98% -9.82% -16.29% -21.65% -19.94% -37.62% -59.08% -68.92% -76.29% -74.30%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
2.46
DCF (Unlevered) 17.05 +593.0%
DCF (Levered) 26.43 +974.2%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM) 50% Bullish
Rating 2026-05 Change
Strong Buy 0 0
Buy 1 0
Hold 0 0
Sell 1 0
Strong Sell 0 0
Quality scores
Altman Z-Score
1.96
Grey zone
Piotroski F-Score
6 / 9
Average
MOAT Score
2 / 10
No MOAT
Composite Rating
A-
Overall Score
4 / 5
High
DCF Score
1 / 5
Low
ROE Score
4 / 5
High
ROA Score
4 / 5
High
D/E Score
3 / 5
Medium
P/E Score
3 / 5
Medium
P/Book Score
5 / 5
High
Operational MOAT
✗ Below peers
  • Revenue growth Medical - Care Facilities: +10.2%
    -6.9% Q4'25: -6.9% (vs Q4'23)
  • EPS growth Medical - Care Facilities: +19.2%
    -13.3% Q4'25: +218.2% (vs Q4'23)
  • FCF margin FCF growth · Medical - Care Facilities: +32.0%
    +4.2% Q4'25: +13.3% (vs Q4'23)
  • EBIT margin Medical - Care Facilities: +11.3%
    +4.6% Q4'25: +4.1% (vs Q4'23)
  • ROIC Medical - Care Facilities: +6.8%
    +4.1% Q4'25: +7.5% (vs Q4'23)
  • Share dilution Medical - Care Facilities: +0.0%
    +0.0% Q4'25: +0.0% (vs Q4'23)
  • Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×
    0.90× Q4'25: 0.47× (vs Q4'23)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.59) × ERP
WACC = 77% × Ke + 23% × Kd (5.7%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
Intrinsic value (base): 17.14 Current price: 2.46
Enterprise Value: Equity Value: Terminal Value: TV as % of EV:

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2013
actual
Dec 2014
actual
Dec 2015
actual
Dec 2016
actual
Dec 2017
actual
Dec 2018
actual
Dec 2019
actual
Dec 2020
actual
Dec 2021
actual
Dec 2022
actual
Dec 2023
actual
Dec 2024
actual
Dec 2025
actual
Dec 2026
2 Rev. Ana.
1 EPS Ana.
Dec 2027
2 Rev. Ana.
1 EPS Ana.
Dec 2028
1 Rev. Ana.
1 EPS Ana.
Revenue
887.35M
est: 800.90M (+10.8%)
1.21B
est: 878.30M (+37.3%)
1.37B
est: 1.63B (-16.0%)
1.53B
est: 1.80B (-14.7%)
1.88B
est: 2.27B (-17.2%)
2.06B
est: 2.30B (-10.4%)
2.12B
est: 2.02B (+4.7%)
2.75B
est: 2.79B (-1.4%)
4.45B
est: 4.23B (+5.1%)
7.90B
est: 6.54B (+20.8%)
10.11B
est: 9.27B (+9.0%)
9.85B
est: 10.52B (-6.3%)
9.18B
est: 9.00B (+2.0%)
9.72B
9.63B – 9.81B
+8.1% YoY
9.96B
9.77B – 10.15B
+2.4% YoY
10.28B
10.13B – 10.43B
+3.2% YoY
EBITDA
171.60M
est: 100.91M (+70.1%)
247.91M
est: 115.74M (+114.2%)
220.92M
est: 365.52M (-39.6%)
-1.40B
est: 269.74M (-619.4%)
519.92M
est: -1.37B (+137.9%)
602.86M
est: 570.36M (+5.7%)
572.37M
est: 547.26M (+4.6%)
372.58M
est: 492.58M (-24.4%)
527.91M
est: 513.34M (+2.8%)
965.25M
est: 647.07M (+49.2%)
1.22B
est: 1.11B (+9.9%)
1.31B
est: 1.04B (+26.2%)
946.57M
est: 1.08B (-12.0%)
1.16B
1.15B – 1.17B
+8.1% YoY
1.19B
1.17B – 1.21B
+2.4% YoY
1.23B
1.21B – 1.25B
+3.2% YoY
EBIT
138.56M
est: 61.01M (+127.1%)
212.12M
est: 155.07M (+36.8%)
179.66M
est: 340.18M (-47.2%)
234.57M
est: 296.70M (-20.9%)
456.57M
est: -1.35B (+133.9%)
533.25M
est: 487.06M (+9.5%)
508.72M
est: 505.28M (+0.7%)
278.11M
est: 469.34M (-40.7%)
367.68M
est: 489.11M (-24.8%)
478.84M
est: 616.53M (-22.3%)
607.78M
est: 604.35M (+0.6%)
752.69M
est: 831.20M (-9.4%)
422.51M
est: 586.28M (-27.9%)
633.71M
627.81M – 639.60M
+8.1% YoY
649.09M
636.79M – 661.38M
+2.4% YoY
669.94M
660.43M – 679.45M
+3.2% YoY
Net Income
89.99M
est: 156.14M (-42.4%)
230.05M
est: 77.28M (+197.7%)
167.05M
est: 245.78M (-32.0%)
-1.51B
est: 176.92M (-951.8%)
421.03M
est: -1.45B (+129.0%)
430.90M
est: 379.06M (+13.7%)
390.87M
est: 365.98M (+6.8%)
310.13M
est: 330.03M (-6.0%)
417.92M
est: 343.94M (+21.5%)
265.86M
est: 291.98M (-8.9%)
257.68M
est: 273.43M (-5.8%)
565.88M
est: 606.63M (-6.7%)
495.94M
est: 518.14M (-4.3%)
474.63M
465.87M – 483.39M
-8.4% YoY
489.14M
480.11M – 498.17M
+3.1% YoY
493.00M
483.90M – 502.10M
+0.8% YoY
SGA
74.13M
est: 86.54M (-14.3%)
85.59M
est: 63.62M (+34.5%)
149.92M
est: 91.44M (+64.0%)
172.06M
est: 158.78M (+8.4%)
211.66M
est: 165.52M (+27.9%)
223.43M
est: 190.56M (+17.2%)
253.57M
est: 189.82M (+33.6%)
337.97M
est: 215.43M (+56.9%)
488.23M
est: 224.51M (+117.5%)
828.19M
est: 283.00M (+192.6%)
973.50M
est: 979.98M (-0.7%)
1.05B
est: 1.11B (-5.5%)
1.02B
est: 950.68M (+7.1%)
1.03B
1.02B – 1.04B
+8.1% YoY
1.05B
1.03B – 1.07B
+2.4% YoY
1.09B
1.07B – 1.10B
+3.2% YoY
EPS
0.16
est: 0.12 (+29.6%)
0.28
est: 0.19 (+45.2%)
0.20
est: 0.32 (-37.2%)
-1.67
est: 0.03 (-4,948.9%)
0.33
est: 0.39 (-16.2%)
0.34
est: 0.37 (-7.4%)
0.31
est: 0.34 (-7.6%)
0.25
est: 0.35 (-27.6%)
0.33
est: 0.38 (-13.3%)
0.21
est: 0.13 (+63.1%)
0.20
est: 0.22 (-7.5%)
0.45
est: 0.48 (-6.2%)
0.39
est: 0.41 (-4.8%)
0.38
0.37 – 0.38
-8.4% YoY
0.39
0.38 – 0.39
+3.1% YoY
0.39
0.38 – 0.40
+0.8% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-29 A- 4/5 1/5 4/5 4/5 3/5 3/5 5/5
2026-05-28 A- 4/5 1/5 4/5 4/5 3/5 3/5 5/5
2026-05-27 A- 4/5 1/5 4/5 4/5 3/5 3/5 5/5
2026-05-26 A- 4/5 1/5 4/5 4/5 3/5 3/5 5/5
2026-05-22 B+ 3/5 1/5 4/5 4/5 3/5 3/5 4/5
2026-05-21 B+ 3/5 1/5 4/5 4/5 3/5 3/5 4/5
2026-05-20 B+ 3/5 1/5 4/5 4/5 3/5 3/5 4/5
2026-05-19 B+ 3/5 1/5 4/5 4/5 3/5 3/5 4/5
2026-05-18 B+ 3/5 1/5 4/5 4/5 3/5 3/5 4/5
2026-05-15 A- 4/5 1/5 4/5 4/5 3/5 3/5 5/5
2026-05-14 A- 4/5 1/5 4/5 4/5 3/5 3/5 5/5
2026-05-13 B+ 3/5 1/5 3/5 4/5 3/5 3/5 5/5
2026-05-12 B+ 3/5 1/5 3/5 4/5 3/5 3/5 5/5
2026-05-11 B+ 3/5 1/5 3/5 4/5 3/5 3/5 5/5
2026-05-08 A- 4/5 1/5 3/5 4/5 3/5 4/5 5/5
2026-05-07 A- 4/5 1/5 3/5 4/5 3/5 4/5 5/5
2026-05-06 A- 4/5 1/5 3/5 4/5 3/5 4/5 5/5
2026-05-05 B+ 3/5 1/5 3/5 4/5 2/5 4/5 5/5
2026-05-04 B+ 3/5 1/5 3/5 4/5 2/5 4/5 5/5
2026-04-30 B+ 3/5 1/5 3/5 4/5 2/5 4/5 5/5
2026-04-29 B+ 3/5 1/5 3/5 4/5 2/5 4/5 5/5
2026-04-28 B+ 3/5 1/5 3/5 4/5 2/5 4/5 5/5
2026-04-27 B+ 3/5 1/5 3/5 4/5 2/5 4/5 5/5
2026-04-24 B+ 3/5 1/5 3/5 4/5 2/5 4/5 5/5
2026-04-23 B+ 3/5 1/5 3/5 5/5 2/5 3/5 5/5
2026-04-22 B+ 3/5 1/5 3/5 5/5 2/5 3/5 5/5
2026-04-21 B+ 3/5 1/5 3/5 5/5 2/5 3/5 5/5
2026-04-20 B+ 3/5 1/5 3/5 5/5 2/5 3/5 5/5
2026-04-17 B+ 3/5 1/5 3/5 5/5 2/5 3/5 5/5
2026-04-16 B+ 3/5 1/5 3/5 5/5 2/5 3/5 5/5
2026-04-15 B+ 3/5 1/5 3/5 5/5 2/5 3/5 5/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
1.72B
OE per share TTM
1.36
Owner's Yield
51.37%
Maintenance CapEx ratio
289.99%
Maint CapEx / Avg PPE
46.9%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
Total invested
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

ETF Ownership

Top ETFs holding this stock Held by 30 ETFs in our universe
# ETF Weight Est. AUM exposure TER
1 State Street SPDR S&P Emerging Markets Small Cap ETF EWX 0.03% 211.4K 0.65%
2 WisdomTree Emerging Markets SmallCap Dividend Fund DGS 0.03% 496.5K 0.58%
3 Avantis Emerging Markets Value ETF AVES 0.02% 305.0K 0.36%
4 WisdomTree Emerging Markets SmallCap Dividend UCITS ETF DGSD.L 0.02% 6.6K 0.54%
5 State Street SPDR S&P China ETF GXC 0.01% 54.9K 0.59%
6 Avantis Emerging Markets Equity UCITS ETF USD Acc AVEM.L 0.01% 29.4K 0.35%
7 Avantis Emerging Markets Small Cap Equity ETF AVEE 0.01% 13.6K 0.42%
8 Vanguard FTSE All-World ex-US Small-Cap ETF VSS 0.01% 1.00M 0.06%
9 Avantis Emerging Markets Equity ETF AVEM 0.01% 1.40M 0.33%
10 Dimensional - Emerging Markets Core Equity 2 ETF DFEM 0.01% 473.5K 0.39%

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
EBIT / Employee
21.2K
Shares Outstanding
1.26B

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Hai Yu Chairman 3M male
Chuang Zhang Chief Executive Officer & Executive Director 231.1K male
Xinchun Wu Executive Director & Vice President 214.9K male
Dayi Gong Vice President male
Bing Zhang Vice President male
Ming Fai Chung Company Secretary male
Yuexing Wang Executive Director male
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend yield history

Dividend history

Earnings history

Earnings reports

Stock splits